SCYNEXIS, Inc.

📍 Jersey City, United States🗓 Founded 2000👥 74 employees💰 Last funded 2006
Biotechnology Research🌐 scynexis.com
Website LinkedIn
At SCYNEXIS, we are bringing a ground-breaking class of drugs to the battle by developing innovative products that have the strength, safety, and versatility to defeat even the most insidious fungal diseases. We are committed to positively impacting the lives of patients suffering from fungal infections — from the most common to the difficult-to-treat and deadliest. (NASDAQ: SCYX) The SCYNEXIS team has deep expertise in anti-infective drug development and marketing, which can be leveraged to advance ibrexafungerp from clinical development to commercialization.
3
Total investors
2
Early stage
0
Mid stage
1
Late stage
2000
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
2
United States
1
Investor activity2000–2006 · investors recorded per year
200012001120061
Recent (last 2y)Earlier
Frequently asked questions
Who invested in SCYNEXIS, Inc.?
SCYNEXIS, Inc. has 3 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did SCYNEXIS, Inc. last raise funding?
The most recent investment in SCYNEXIS, Inc. recorded on gritt.io was in 2006.
When was SCYNEXIS, Inc. founded?
SCYNEXIS, Inc. was founded in 2000.
What industry is SCYNEXIS, Inc. in?
SCYNEXIS, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SCYNEXIS, Inc. based?
SCYNEXIS, Inc. is headquartered in Jersey City, United States.